|
Research & Development
> Servier Research & Development
Servier Research & Development
R&D is the motor driving innovation and progress
 Unmatched levels of investment
R&D investment accounts for almost 25% of turnover
3,000 people devote themselves to Research and Development
- 78 new R&D projects are in progress
- 32 projects of research
- 38 drugs are currently under development
- 8 projects on drugs undergoing registration
- 30 drugs registered in 30 years
- All SERVIER drugs currently produced were developed by SERVIER's own R&D
- SERVIER is one of the foremost private partners of the French National Health and Medical Research Institute (INSERM); it is also a privileged partner of the French National Centre for Scientific Research (CNRS).
The main lines of Servier Research
- Neurosciences
- Oncology
- Cardiovascular disease
- Metabolic disease
- Rheumatology
- Basic research
|
print
